Intelligence Platform

Patents

Browse 169 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 7105695

Synthesis of combretastatin A-2 prodrugs

ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7078552

Combretastatin A-1 phosphate and combretastatin B-1 phosphate prodrugs

THE ARIZONA BOARD OF REGENTS · Granted Tue Jul 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7037501

Myostatin immnoconjugate

Regents of the University of Minnesota · Granted Tue May 02 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7018987

Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof

ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Mar 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7001919

Forms of pravastatin sodium

Teva Gyogyszergyar Reszvenytarsasag · Granted Tue Feb 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6992194

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jan 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6949647

Synthesis of pancratistatin

THE ARIZONA BOARD OF REGENTS · Granted Tue Sep 27 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6943194

Synthesis of phenstatin and prodrugs thereof

ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Sep 13 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6936731

Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and comp

TEVA Gyógyszergyár Részvénytársaság · Granted Tue Aug 30 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6825167

Genetic modification of endostatin

Regents of the University of Minnesota · Granted Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6777578

Hydroxyphenstatin and the prodrugs thereof

THE ARIZONA BOARD OF REGENTS · Granted Tue Aug 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6686445

Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same

ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6605636

Atorvastatin hemi-calcium form VII

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 12 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6599495

Nucleotide and protein sequence of mammastatin and methods of use

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6596690

Vasostatin as marrow protectant

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6576609

Methods and compositions for generating angiostatin

Northwestern University · Granted Tue Jun 10 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6492504

Nucleotide sequence of mammastatin and methods of use

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 10 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6451765

Methods for treating breast cancer using Mammastatin

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6444431

Angiostatin receptor

Northwestern University · Granted Tue Sep 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6437128

Cribrostatins 3-5

THE ARIZONA BOARD OF REGENTS · Granted Tue Aug 20 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6352982

4,1-benzoxazepines, their analogues, and their use as somatostatin agonists

Takeda Chemical Industries Ltd. · Granted Tue Mar 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6281196

Isolation and structural elucidation of the human cancer cell growth inhibitory compound d

THE ARIZONA BOARD OF REGENTS · Granted Tue Aug 28 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6239104

Isolation and structural elucidation of the cytostatic linear and cyclo-depsipeptides dola

THE ARIZONA BOARD OF REGENTS · Granted Tue May 29 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6060505

Method of treating cancer using C-26 modified bryostatin

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)